This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bar-Ilan University, Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines S.e.c., Universitéde Montreal. Active years: 2026.
Company Filing History:
1 out of 244 
1 out of 10 
1 out of 189 
Years Active: 2026
Title: Suresh Vutla: Innovator in Synthetic Cyclic Peptide Mimetics
Introduction
Suresh Vutla is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of synthetic cyclic peptide mimetics, which have potential applications in diagnosing and treating amyloidogenic diseases. His innovative work has led to the development of a unique patent that showcases his expertise in this area.
Latest Patents
Suresh Vutla holds a patent for "Synthetic cyclic peptide mimetics." This patent describes synthetic cyclic peptide mimetics that comprise alternating D-amino acids and L-amino acids, along with amino acid derivatives such as aza-amino acids and azasulfuryl-amino acids. The cyclic peptide mimetics may also be conjugated to another agent via a linker to form cyclic peptide mimetic conjugates. These mimetics are designed for use as diagnostic or therapeutic agents in the diagnosis or treatment of amyloidogenic diseases.
Career Highlights
Throughout his career, Suresh Vutla has worked with prestigious institutions, including Bar-Ilan University and Université de Montréal. His work in these organizations has allowed him to further his research and contribute to advancements in the field of peptide mimetics.
Collaborations
Suresh has collaborated with notable colleagues such as Shai Rahimipour and Maram Habashi. These collaborations have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Suresh Vutla is a distinguished inventor whose work in synthetic cyclic peptide mimetics has the potential to revolutionize the diagnosis and treatment of amyloidogenic diseases. His contributions to the field are noteworthy and reflect his dedication to innovation.